Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PM9D
|
|||
| Former ID |
DIB008479
|
|||
| Drug Name |
Porfiromycin
|
|||
| Synonyms |
Porfiromycine; Promycin; ENT-50825; N-methylmitomycin C; U-14743
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Head and neck cancer [ICD-11: 2D42] | Phase 3 | [1] | |
| Company |
Vion Pharmaceuticals Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H20N4O5
|
|||
| Canonical SMILES |
CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4C)N
|
|||
| InChI |
1S/C16H20N4O5/c1-6-10(17)13(22)9-7(5-25-15(18)23)16(24-3)14-8(19(14)2)4-20(16)11(9)12(6)21/h7-8,14H,4-5,17H2,1-3H3,(H2,18,23)/t7-,8+,14+,16-,19?/m1/s1
|
|||
| InChIKey |
HRHKSTOGXBBQCB-VFWICMBZSA-N
|
|||
| CAS Number |
CAS 801-52-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02183246) Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.